Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2/3 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 13FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 1Bowen's Disease 1

Interventions

Imiquimod 2Docetaxel 2Celecoxib 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2pembrolizumab 1pasireotide 1gadolinium ethoxybenzyl DTPA 1enzalutamide 1Uterine Myomectomy 1Topotecan 1Tablets 1Sildenafil Citrate 1Reference Standards 1Pentoxifylline 1Mindfulness 1Mass Screening 1Ketoconazole 1Itraconazole 1Hysterectomy 1Hypnosis 1Herpes Zoster Vaccine 1Fecal Microbiota Transplantation 1Exercise 1Estramustine 1Epirubicin 1Doxycycline 1Cryotherapy 1Biopsy, Large-Core Needle 1Azacitidine 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × FED × Imiquimod × Clear all
NCT03116659 2019-08-13

CTCL Directed Therapy

James J. Peters Veterans Affairs Medical Center

Phase EARLY_PHASE1 Unknown
8 enrolled
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT00384124 2008-03-26

Topical Imiquimod for Bowen's Disease of the Head and Neck

Brooke Army Medical Center

Phase 2/3 Unknown
50 enrolled

Bowen's Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡